[Coenzyme metabolic therapy in infectious allergic myocarditis].
A trial was performed of clinical efficacy of the coenzyme complex incorporating piridoxalphosphate, cobamamide and phosphaden in patients with infectious allergic myocarditis. Myo- cardial dystrophy and correlations of the myocardial enzymatic status with blood lymphocytes in the above patients were taken in consideration. Corrective action of metabolic therapy on myocardial bioenergy was coupled with positive antiarrhythmic and cardiotonic effects. Cytochemical follow-up investigations enabled long-term monitoring over the patients' condition and further catamnesis.
Mazurets
A F
AF
Gurevich
M A
MA
Kubyshkin
V F
VF
Dziuba
M V
MV
Vikharev
N P
NP
D000249:Adenosine Monophosphate / Q000008:administration & dosage*; D000328:Adult; D000368:Aged; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006651:Histocytochemistry; D006801:Humans; D008297:Male; D008875:Middle Aged; D009205:Myocarditis / Q000188:drug therapy* / Q000201:enzymology / Q000209:etiology; D011732:Pyridoxal Phosphate / Q000008:administration & dosage*; D013997:Time Factors; D014805:Vitamin B 12 / Q000008:administration & dosage*
D000249:Adenosine Monophosphate; D011732:Pyridoxal Phosphate; D014805:Vitamin B 12